Internal Medicine, Endocrinology, Diabetes, & Metabolism · Seattle, WA
NPI
1902892680
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
515 Minor Ave, Ste 300
Seattle, WA, 98104
Phone (206) 386-9500
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
956 services
Medicare patients, 2024
435
Average age 73
Drug cost, 2024
$2.3M
5,558 prescriptions
Company payments, 2025
$16.02
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew D Davies was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 394 times for 320 patients. In total Matthew D Davies billed 956 services in 10 codes, and Medicare paid $61K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 394 | 320 | $13.31 | $5,244 |
| 99214 Office E&M - Established | Office | 352 | 262 | $98.12 | $35K |
| 99213 Office E&M - Established | Office | 78 | 76 | $68.04 | $5,307 |
| 99204 Office E&M - New | Office | 64 | 64 | $132.29 | $8,467 |
| 99215 Office E&M - Established | Office | 32 | 30 | $125.84 | $4,027 |
| 99205 Office E&M - New | Office | 13 | 13 | $160.66 | $2,089 |
By year: 2022 $66K for 823 services; 2023 $63K for 696 services; 2024 $61K for 956 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew D Davies prescribed most often to Medicare patients was Levothyroxine Sodium, with 780 prescriptions and refills. In total Matthew D Davies wrote 5,558 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 780 | 2,228 | 221 | $9,300 |
| Jardiance Empagliflozin | 328 | 825 | 83 | $462K |
| Metformin Hcl Er Metformin Hcl | 243 | 669 | 70 | $3,205 |
| Testosterone Cypionate Generic | 241 | 300 | 46 | $7,126 |
| Glipizide Er Glipizide | 197 | 540 | 52 | $2,095 |
| Ozempic Semaglutide | 191 | 297 | 47 | $279K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 189 | 460 | 64 | $34K |
| Liothyronine Sodium Generic | 173 | 504 | 54 | $7,145 |
| Synthroid Levothyroxine Sodium | 161 | 432 | 39 | $11K |
| Methimazole Generic | 142 | 325 | 32 | $1,687 |
| Metformin Hcl Generic | 138 | 412 | 44 | $2,116 |
| Trulicity Dulaglutide | 115 | 200 | 31 | $198K |
| Hydrocortisone Generic | 103 | 201 | 22 | $5,143 |
| Atorvastatin Calcium Generic | 96 | 272 | 29 | $673 |
| Simvastatin Generic | 90 | 264 | 25 | $855 |
Brand drugs: 2,214 claims; generic drugs: 3,042 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew D Davies $16.02 ($16.02 in general payments such as food, travel and fees) from 1 company. The largest payer was Sequel Med Tech, LLC with $16.02.
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 1 | $16.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.